SEC Info - Marpai, Inc. - ‘8-K’ for 8/25/22

SEC Info℠

Home

Help

Please Sign In

Marpai, Inc. – ‘8-K’ for 8/25/22

On: Thursday, 8/25/22, at 9:00am ET · For: 8/25/22 · Accession #: 1104659-22-94255 · File #: 1-40904

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/25/22  Marpai, Inc.                      8-K:8,9     8/25/22   11:212K                                   Toppan Merrill/FA

Current Report — Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     27K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     15K 
 6: R1          Cover                                               HTML     47K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- tm2224526d1_8k_htm                  XML     15K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 4: EX-101.LAB  XBRL Labels -- mrai-20220825_lab                     XML     96K 
 5: EX-101.PRE  XBRL Presentations -- mrai-20220825_pre              XML     64K 
 3: EX-101.SCH  XBRL Schema -- mrai-20220825                         XSD     12K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    33K 
11: ZIP         XBRL Zipped Folder -- 0001104659-22-094255-xbrl      Zip     20K

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

iX: C: C: C: C: C: C: C: C:

i 0001844392 i false 0001844392 2022-08-25 2022-08-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form i 8-K

CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): i August 25, 2022

i MARPAI, INC.

(Exact name of registrant as specified in its charter)

i 001-40904

(Commission File Number)

i Delaware	i 86-1916231
(State or other jurisdiction of incorporation)	(I.R.S. Employer Identification No.)

i 5701 East Hillsborough Avenue, Suite 1417,
i Tampa, i Florida i 33610

(Address of principal executive offices, with zip code)

( i 646) i 303-3483

(Registrant's telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

i ¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

i ¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

i ¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

i ¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Ticker symbol(s)	Name of each exchange on which registered
i Class A Common Stock, par value $0.0001 per share	i MRAI	The i Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company i x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. i ¨

Item 8.01 Other Events.

On August 25, 2022, Marpai, Inc. (“Marpai” or the “Company”) issued a press release announcing a new pharmacy benefit management (PBM) solution available to its clients nationwide called MarpaiRx. A copy of the press release is attached as Exhibit 99.1 hereto and is incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number		Description
99.1		Press release of Marpai, Inc., dated August 25, 2022
104		Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MARPAI, INC.

Date: August 25, 2022	By:	/s/ *Edmundo Gonzalez*
	Name:	Edmundo Gonzalez
	Title:	Chief Executive Officer

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K’ Filing	Date	Other Filings

Filed on / For Period end:	8/25/22	None on these Dates
		List all Filings

3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/19/23  Marpai, Inc.                      424B5                  1:266K                                   Donnelley … Solutions/FA
 4/17/23  Marpai, Inc.                      424B5                  1:269K                                   Donnelley … Solutions/FA
 1/20/23  Marpai, Inc.                      S-3                    4:234K                                   Donnelley … Solutions/FA

↑Top

Filing Submission 0001104659-22-094255 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)